Compare AVNT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVNT | TXG |
|---|---|---|
| Founded | 1927 | 2012 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 2.8B |
| IPO Year | N/A | N/A |
| Metric | AVNT | TXG |
|---|---|---|
| Price | $43.14 | $18.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 14 |
| Target Price | ★ $46.33 | $16.39 |
| AVG Volume (30 Days) | 975.8K | ★ 2.8M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.81 | N/A |
| Revenue Next Year | $3.34 | $7.32 |
| P/E Ratio | $48.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.48 | $6.78 |
| 52 Week High | $44.85 | $23.56 |
| Indicator | AVNT | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 83.01 | 47.64 |
| Support Level | $38.30 | $17.26 |
| Resistance Level | $44.85 | $20.89 |
| Average True Range (ATR) | 1.37 | 1.27 |
| MACD | 0.42 | -0.30 |
| Stochastic Oscillator | 82.53 | 36.64 |
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).